BioCentury
ARTICLE | Company News

Nucleonics, University of California deal

June 7, 2004 7:00 AM UTC

Nucleonics acquired an exclusive license from the university to IP covering a class of eukaryotic RNA polymerase III promoters for transcribing expressed interefering RNAs. Nucleonics is developing RN...